theirpossible inclusion intable Iortable11annexed tothe1988Convention, if ithasobjective reasons tobelieve thatsuchaction wouldresultinreducing the illicit manufacture ofdrugswithout adverse effects ontheavailability ofthose substances forlicitpurposes. Theeffectiveness ofthecontrol ofnarcotic drugs andpsychotropic substances reststoagreatextent ontheimplementation ofthe 1988Convention. Theperiodic reporting ontheillicit movement ofsubstances listed intableIandtable11ofthe1988Convention byanational co-ordinating bodyofthevarious competent authorities provides INCB,andthroughitthe parties, withmeanstoascertain theextent towhichtheparties aredischarging theirobligations. 28.52 Accordingly, theobjectives ofthesubprogramme are: (a)Toassess anysubstance proposed byapartyunderarticle 12, paragraph 2,ofthe1988Convention tobescheduled, rescheduled ordescheduled; (b)Toidentify andmonitor solvents, precursors andessential chemicals widely usedintheillicit manufacture ofdrugsfortheirassessment andpossible inclusion intable Iortable11ofthe1988Convention; (c)Tosurvey constantly theprocesses ofillicit manufacture ofdrugs,in ordertoidentify substances which,ifbrought underthecontrol ofthe1988 Convention, wouldprevent theillicit manufacture or.reduce considerably its magnitude without hampering thelicitactivities basedonthemanufacture, distribution anduseofthosesubstances andinitiate, whennecessary, the procedure underarticle 12,paragraph 2,thatmayleadtoachangeinthescopeof control underthe1988Convention. (b)Course ofaction oftheSecretariat 28.53 Inordertomeettheobjectives outlined above,theelaboration ofcriteria permitting anobjective assessment ofsubstances willbeestablished basedon: (a)Criteria tomeasure theextent, importance anddiversity ofthelicituse; -15- .'~' .:~ Digitized by Dag Hammarskjöld Library(b)Criteria tomeasure theeaseofusingalternate substances forbothlicit purposes andillicit manufacture; (c)Criteria todetermine thedegree offrequency ofuseofasubstance in illicit manufacture thatwarrant placing thatsubstance underinternational control; (d)Criteria tomeasure theseriousness ofpublichealth andsocial problems andthedegrees ofseriousness ofthoseproblems thatwarrant placing asubstance underinternational control. 28.54 Inaddition, INcawill: (a)Evaluate thelikelyeffects ofchanging thescopeofcontrol onboththe licitandtheillicit manufacture ofdrugs; (b)Recommend appropriate monitoring measures totheCommission onNarcotic Drugsbasedonsurveys ofcontrol practices andillicit manufacture processes and practices; (c)Elaborate theassessment ofsubstances tobeplaced before theCommission onNarcotic Drugs; (d)Submit comments totheEconomic andSocial Council relating toany request byapartytotheConvention toreview adecision oftheCommission taken underarticle 12,paragraph 5; (e)Ensurethatthemeasures established bythe1988Convention tocontrol thesubstances listedintableIandtableIIofthatConvention areimplemented; (f)Detect diversions ofsubstances listedintableIandtableIIofthe Convention fortheillicit manufacture ofdrugs, analyse thereason ofsuch diversion andrecommend anycorrective action needed. -16- Digitized by Dag Hammarskjöld Library
**Analysis**
The text appears to be discussing the international control of narcotic drugs and psychotropic substances, with a focus on assessing the effectiveness of the 1988 Convention and identifying substances for possible inclusion in the Convention's schedules. The language used is technical and legal, suggesting a focus on international cooperation and regulation.

**Category**
Health, International trade